The research team projects that the Molecular Biomarkers market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Alere
Atossa Genetics
Biophysical
Abbott
BioCept
BioTheranostics
DiagnoCure
GenomeDx
Genomic Health
Gen-Probe
Life Technologies
20/20 GeneSystems
Cynvenio
Dako (Agilent)
Epic Sciences
Foundation Medicine
Genomic Health
Molecular Response
Nodality
PGD
By Type
Type I
Type II
By Application
Application I
Application II
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
Russia
Spain
Netherlands
Switzerland
Poland
South Asia
India
Pakistan
Bangladesh
Southeast Asia
Indonesia
Thailand
Singapore
Malaysia
Philippines
Vietnam
Myanmar
Middle East
Turkey
Saudi Arabia
Iran
United Arab Emirates
Israel
Iraq
Qatar
Kuwait
Oman
Africa
Nigeria
South Africa
Egypt
Algeria
Morocoo
Oceania
Australia
New Zealand
South America
Brazil
Argentina
Colombia
Chile
Venezuela
Peru
Puerto Rico
Ecuador
Rest of the World
Kazakhstan
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Molecular Biomarkers 2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Molecular Biomarkers Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).
Markat Analysis by Application Type: Based on the Molecular Biomarkers Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Molecular Biomarkers market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Molecular Biomarkers Market Size Analysis from 2022 to 2027
1.5.1 Global Molecular Biomarkers Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Molecular Biomarkers Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Molecular Biomarkers Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Molecular Biomarkers Industry Impact
Chapter 2 Global Molecular Biomarkers Competition by Types, Applications, and Top Regions and Countries
2.1 Global Molecular Biomarkers (Volume and Value) by Type
2.1.1 Global Molecular Biomarkers Consumption and Market Share by Type (2016-2021)
2.1.2 Global Molecular Biomarkers Revenue and Market Share by Type (2016-2021)
2.2 Global Molecular Biomarkers (Volume and Value) by Application
2.2.1 Global Molecular Biomarkers Consumption and Market Share by Application (2016-2021)
2.2.2 Global Molecular Biomarkers Revenue and Market Share by Application (2016-2021)
2.3 Global Molecular Biomarkers (Volume and Value) by Regions
2.3.1 Global Molecular Biomarkers Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Molecular Biomarkers Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Molecular Biomarkers Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Molecular Biomarkers Consumption by Regions (2016-2021)
4.2 North America Molecular Biomarkers Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Molecular Biomarkers Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Molecular Biomarkers Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Molecular Biomarkers Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Molecular Biomarkers Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Molecular Biomarkers Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Molecular Biomarkers Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Molecular Biomarkers Sales, Consumption, Export, Import (2016-2021)
4.10 South America Molecular Biomarkers Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Molecular Biomarkers Market Analysis
5.1 North America Molecular Biomarkers Consumption and Value Analysis
5.1.1 North America Molecular Biomarkers Market Under COVID-19
5.2 North America Molecular Biomarkers Consumption Volume by Types
5.3 North America Molecular Biomarkers Consumption Structure by Application
5.4 North America Molecular Biomarkers Consumption by Top Countries
5.4.1 United States Molecular Biomarkers Consumption Volume from 2016 to 2021
5.4.2 Canada Molecular Biomarkers Consumption Volume from 2016 to 2021
5.4.3 Mexico Molecular Biomarkers Consumption Volume from 2016 to 2021
Chapter 6 East Asia Molecular Biomarkers Market Analysis
6.1 East Asia Molecular Biomarkers Consumption and Value Analysis
6.1.1 East Asia Molecular Biomarkers Market Under COVID-19
6.2 East Asia Molecular Biomarkers Consumption Volume by Types
6.3 East Asia Molecular Biomarkers Consumption Structure by Application
6.4 East Asia Molecular Biomarkers Consumption by Top Countries
6.4.1 China Molecular Biomarkers Consumption Volume from 2016 to 2021
6.4.2 Japan Molecular Biomarkers Consumption Volume from 2016 to 2021
6.4.3 South Korea Molecular Biomarkers Consumption Volume from 2016 to 2021
Chapter 7 Europe Molecular Biomarkers Market Analysis
7.1 Europe Molecular Biomarkers Consumption and Value Analysis
7.1.1 Europe Molecular Biomarkers Market Under COVID-19
7.2 Europe Molecular Biomarkers Consumption Volume by Types
7.3 Europe Molecular Biomarkers Consumption Structure by Application
7.4 Europe Molecular Biomarkers Consumption by Top Countries
7.4.1 Germany Molecular Biomarkers Consumption Volume from 2016 to 2021
7.4.2 UK Molecular Biomarkers Consumption Volume from 2016 to 2021
7.4.3 France Molecular Biomarkers Consumption Volume from 2016 to 2021
7.4.4 Italy Molecular Biomarkers Consumption Volume from 2016 to 2021
7.4.5 Russia Molecular Biomarkers Consumption Volume from 2016 to 2021
7.4.6 Spain Molecular Biomarkers Consumption Volume from 2016 to 2021
7.4.7 Netherlands Molecular Biomarkers Consumption Volume from 2016 to 2021
7.4.8 Switzerland Molecular Biomarkers Consumption Volume from 2016 to 2021
7.4.9 Poland Molecular Biomarkers Consumption Volume from 2016 to 2021
Chapter 8 South Asia Molecular Biomarkers Market Analysis
8.1 South Asia Molecular Biomarkers Consumption and Value Analysis
8.1.1 South Asia Molecular Biomarkers Market Under COVID-19
8.2 South Asia Molecular Biomarkers Consumption Volume by Types
8.3 South Asia Molecular Biomarkers Consumption Structure by Application
8.4 South Asia Molecular Biomarkers Consumption by Top Countries
8.4.1 India Molecular Biomarkers Consumption Volume from 2016 to 2021
8.4.2 Pakistan Molecular Biomarkers Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Molecular Biomarkers Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Molecular Biomarkers Market Analysis
9.1 Southeast Asia Molecular Biomarkers Consumption and Value Analysis
9.1.1 Southeast Asia Molecular Biomarkers Market Under COVID-19
9.2 Southeast Asia Molecular Biomarkers Consumption Volume by Types
9.3 Southeast Asia Molecular Biomarkers Consumption Structure by Application
9.4 Southeast Asia Molecular Biomarkers Consumption by Top Countries
9.4.1 Indonesia Molecular Biomarkers Consumption Volume from 2016 to 2021
9.4.2 Thailand Molecular Biomarkers Consumption Volume from 2016 to 2021
9.4.3 Singapore Molecular Biomarkers Consumption Volume from 2016 to 2021
9.4.4 Malaysia Molecular Biomarkers Consumption Volume from 2016 to 2021
9.4.5 Philippines Molecular Biomarkers Consumption Volume from 2016 to 2021
9.4.6 Vietnam Molecular Biomarkers Consumption Volume from 2016 to 2021
9.4.7 Myanmar Molecular Biomarkers Consumption Volume from 2016 to 2021
Chapter 10 Middle East Molecular Biomarkers Market Analysis
10.1 Middle East Molecular Biomarkers Consumption and Value Analysis
10.1.1 Middle East Molecular Biomarkers Market Under COVID-19
10.2 Middle East Molecular Biomarkers Consumption Volume by Types
10.3 Middle East Molecular Biomarkers Consumption Structure by Application
10.4 Middle East Molecular Biomarkers Consumption by Top Countries
10.4.1 Turkey Molecular Biomarkers Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Molecular Biomarkers Consumption Volume from 2016 to 2021
10.4.3 Iran Molecular Biomarkers Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Molecular Biomarkers Consumption Volume from 2016 to 2021
10.4.5 Israel Molecular Biomarkers Consumption Volume from 2016 to 2021
10.4.6 Iraq Molecular Biomarkers Consumption Volume from 2016 to 2021
10.4.7 Qatar Molecular Biomarkers Consumption Volume from 2016 to 2021
10.4.8 Kuwait Molecular Biomarkers Consumption Volume from 2016 to 2021
10.4.9 Oman Molecular Biomarkers Consumption Volume from 2016 to 2021
Chapter 11 Africa Molecular Biomarkers Market Analysis
11.1 Africa Molecular Biomarkers Consumption and Value Analysis
11.1.1 Africa Molecular Biomarkers Market Under COVID-19
11.2 Africa Molecular Biomarkers Consumption Volume by Types
11.3 Africa Molecular Biomarkers Consumption Structure by Application
11.4 Africa Molecular Biomarkers Consumption by Top Countries
11.4.1 Nigeria Molecular Biomarkers Consumption Volume from 2016 to 2021
11.4.2 South Africa Molecular Biomarkers Consumption Volume from 2016 to 2021
11.4.3 Egypt Molecular Biomarkers Consumption Volume from 2016 to 2021
11.4.4 Algeria Molecular Biomarkers Consumption Volume from 2016 to 2021
11.4.5 Morocco Molecular Biomarkers Consumption Volume from 2016 to 2021
Chapter 12 Oceania Molecular Biomarkers Market Analysis
12.1 Oceania Molecular Biomarkers Consumption and Value Analysis
12.2 Oceania Molecular Biomarkers Consumption Volume by Types
12.3 Oceania Molecular Biomarkers Consumption Structure by Application
12.4 Oceania Molecular Biomarkers Consumption by Top Countries
12.4.1 Australia Molecular Biomarkers Consumption Volume from 2016 to 2021
12.4.2 New Zealand Molecular Biomarkers Consumption Volume from 2016 to 2021
Chapter 13 South America Molecular Biomarkers Market Analysis
13.1 South America Molecular Biomarkers Consumption and Value Analysis
13.1.1 South America Molecular Biomarkers Market Under COVID-19
13.2 South America Molecular Biomarkers Consumption Volume by Types
13.3 South America Molecular Biomarkers Consumption Structure by Application
13.4 South America Molecular Biomarkers Consumption Volume by Major Countries
13.4.1 Brazil Molecular Biomarkers Consumption Volume from 2016 to 2021
13.4.2 Argentina Molecular Biomarkers Consumption Volume from 2016 to 2021
13.4.3 Columbia Molecular Biomarkers Consumption Volume from 2016 to 2021
13.4.4 Chile Molecular Biomarkers Consumption Volume from 2016 to 2021
13.4.5 Venezuela Molecular Biomarkers Consumption Volume from 2016 to 2021
13.4.6 Peru Molecular Biomarkers Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Molecular Biomarkers Consumption Volume from 2016 to 2021
13.4.8 Ecuador Molecular Biomarkers Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Molecular Biomarkers Business
14.1 Alere
14.1.1 Alere Company Profile
14.1.2 Alere Molecular Biomarkers Product Specification
14.1.3 Alere Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Atossa Genetics
14.2.1 Atossa Genetics Company Profile
14.2.2 Atossa Genetics Molecular Biomarkers Product Specification
14.2.3 Atossa Genetics Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Biophysical
14.3.1 Biophysical Company Profile
14.3.2 Biophysical Molecular Biomarkers Product Specification
14.3.3 Biophysical Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Abbott
14.4.1 Abbott Company Profile
14.4.2 Abbott Molecular Biomarkers Product Specification
14.4.3 Abbott Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 BioCept
14.5.1 BioCept Company Profile
14.5.2 BioCept Molecular Biomarkers Product Specification
14.5.3 BioCept Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 BioTheranostics
14.6.1 BioTheranostics Company Profile
14.6.2 BioTheranostics Molecular Biomarkers Product Specification
14.6.3 BioTheranostics Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 DiagnoCure
14.7.1 DiagnoCure Company Profile
14.7.2 DiagnoCure Molecular Biomarkers Product Specification
14.7.3 DiagnoCure Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 GenomeDx
14.8.1 GenomeDx Company Profile
14.8.2 GenomeDx Molecular Biomarkers Product Specification
14.8.3 GenomeDx Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Genomic Health
14.9.1 Genomic Health Company Profile
14.9.2 Genomic Health Molecular Biomarkers Product Specification
14.9.3 Genomic Health Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Gen-Probe
14.10.1 Gen-Probe Company Profile
14.10.2 Gen-Probe Molecular Biomarkers Product Specification
14.10.3 Gen-Probe Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Life Technologies
14.11.1 Life Technologies Company Profile
14.11.2 Life Technologies Molecular Biomarkers Product Specification
14.11.3 Life Technologies Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 20/20 GeneSystems
14.12.1 20/20 GeneSystems Company Profile
14.12.2 20/20 GeneSystems Molecular Biomarkers Product Specification
14.12.3 20/20 GeneSystems Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Cynvenio
14.13.1 Cynvenio Company Profile
14.13.2 Cynvenio Molecular Biomarkers Product Specification
14.13.3 Cynvenio Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Dako (Agilent)
14.14.1 Dako (Agilent) Company Profile
14.14.2 Dako (Agilent) Molecular Biomarkers Product Specification
14.14.3 Dako (Agilent) Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 Epic Sciences
14.15.1 Epic Sciences Company Profile
14.15.2 Epic Sciences Molecular Biomarkers Product Specification
14.15.3 Epic Sciences Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 Foundation Medicine
14.16.1 Foundation Medicine Company Profile
14.16.2 Foundation Medicine Molecular Biomarkers Product Specification
14.16.3 Foundation Medicine Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.17 Genomic Health
14.17.1 Genomic Health Company Profile
14.17.2 Genomic Health Molecular Biomarkers Product Specification
14.17.3 Genomic Health Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.18 Molecular Response
14.18.1 Molecular Response Company Profile
14.18.2 Molecular Response Molecular Biomarkers Product Specification
14.18.3 Molecular Response Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.19 Nodality
14.19.1 Nodality Company Profile
14.19.2 Nodality Molecular Biomarkers Product Specification
14.19.3 Nodality Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.20 PGD
14.20.1 PGD Company Profile
14.20.2 PGD Molecular Biomarkers Product Specification
14.20.3 PGD Molecular Biomarkers Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Molecular Biomarkers Market Forecast (2022-2027)
15.1 Global Molecular Biomarkers Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Molecular Biomarkers Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Molecular Biomarkers Value and Growth Rate Forecast (2022-2027)
15.2 Global Molecular Biomarkers Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Molecular Biomarkers Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Molecular Biomarkers Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Molecular Biomarkers Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Molecular Biomarkers Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Molecular Biomarkers Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Molecular Biomarkers Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Molecular Biomarkers Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Molecular Biomarkers Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Molecular Biomarkers Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Molecular Biomarkers Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Molecular Biomarkers Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Molecular Biomarkers Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Molecular Biomarkers Consumption Forecast by Type (2022-2027)
15.3.2 Global Molecular Biomarkers Revenue Forecast by Type (2022-2027)
15.3.3 Global Molecular Biomarkers Price Forecast by Type (2022-2027)
15.4 Global Molecular Biomarkers Consumption Volume Forecast by Application (2022-2027)
15.5 Molecular Biomarkers Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Request Sample 
Request Discount 
Inquire Before Buy
